Rachael Vaubel
Molecular Genetic Pathology Rochester, MN Medical Doctor
NPI 1992140982 CMS profile 391213
200 1St St Sw, Rochester, MN 55905
General payments
$1,077
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Rachael Vaubel of Rochester, MN is reported in the CMS Open Payments database as having received $1,077 across 2 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $1,077 | 2 |
Beside peers
- Rachael Vaubel
- Molecular Genetic Pathology median
- Middle half of Molecular Genetic Pathology
- National median
In program year 2025, general payments to Rachael Vaubel were reported at $0. Among 27 Molecular Genetic Pathology profiles paid that year, the median was $225 and the middle half received between $91 and $3,596.
Show as a table
| Year | Rachael Vaubel | Molecular Genetic Pathology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $131 | $38–$1,524 | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | $900 | $25–$1,899 | $132 |
| 2022 | $0 | $136 | $28–$4,738 | $149 |
| 2023 | $0 | $139 | $48–$3,150 | $160 |
| 2024 | $1,077 | $1,077 | $71–$2,833 | $164 |
| 2025 | $0 | $225 | $91–$3,596 | $169 |
Breakdown
Billing to Medicare
Part B · data year 2024 · 8 billing codesPaid by Medicare
$3,537
Medicare patients
18
Services billed
86
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| Alzheimer's or dementia | 0% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
2 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Molecular Genetic Pathology in Minnesota
Related records
Molecular Genetic Pathology in Minnesota
Practitioners in the same specialty and state, ranked by reported value.
All Molecular Genetic Pathology
Everyone recorded under this specialty, nationwide.
Doctors in Minnesota
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.